Previously seen as a rare neoplasm the incidence of esophageal adenocarcinoma has risen quickly in recent decades. Smad4 reduction by immunohistochemistry in 21 PI3k-delta inhibitor 1 of 205 (10%) tumors which Smad4 reduction correlated with an increase of postoperative recurrence (was at the mercy of copy number reduction PI3k-delta inhibitor 1 in 34% of tumors.… Continue reading Previously seen as a rare neoplasm the incidence of esophageal adenocarcinoma